EndoForums

The choice to end your dearly wanted pregnancy is so heartbreaking. It is very personal; it is never a "black or white" choice.

Fri, 11 Dec 2009 11:00:00 +1800

I've been asked to write "our side" of the story for terminating a pregnancy due to T-21 with known health issues. This is my story in much abbreviated form.

I was 39 when I found out I had severe endometriosis, and I underwent a laparoscopy and six months of Lupron treatment to combat it.

Neurocrine rises on clinical results

Fri, 11 Dec 2009 11:00:00 +1800

Shares of Neurocrine Biosciences Inc. (Nasdaq: NBIX) lifted in after-hours trading after the San Diego-based company said its endometriosis treatment proved safe and effective in its fifth Phase 2 clinical trial.

Bayer: Visanne Cleared In Europe For Endometriosis Treatment

Fri, 11 Dec 2009 11:00:00 +1800

FRANKFURT -(Dow Jones)- Bayer Schering Pharma AG has successfully completed the decentralized part of drug approval procedure in Europe for a new treatment of endometriosis called Visanne, the company said Monday.

LUNA does not alleviate chronic pelvic pain

Fri, 11 Dec 2009 11:00:00 +1800

Clinical question Is laparoscopic uterosacral nerve ablation (LUNA) effective for the treatment of women with chronic pelvic pain?

Bottom line LUNA is no more effective than sham surgery in alleviating chronic pelvic pain of uncertain etiology in adult women. (Level of evidence = 1bâ)

Synopsis LUNA is a therapeutic procedure performed after a diagnostic laparoscopy in women with chronic pelvic pain of uncertain etiology

Cook Medical offers preview of its new uterine injectors

Sat, 28 Nov 2009 09:50:00 +1800

Cook Medical has allowed those in the medical industry to preview its new uterine manipulator/injectors (UMI) at the recent Global Congress of Minimally Invasive Gynaecology.

The company's new UMI and UMI-Loc products are designed to improve laparoscopic procedures during the diagnosis and treatment of common gynecological problems, including infertility, pelvic organ prolapse, endometriosis and uterine fibroids.

Woman wrongly diagnosed left 'devastated'

Sat, 28 Nov 2009 09:50:00 +1800

A Wigan woman is to take legal action against doctors after she had a hysterectomy after being misdiagnosed with ovarian cancer.
Tracey Murray had hoped to have children but underwent the radical surgery to remove her womb and ovaries at Salford Royal Hospital because she believed her life was in danger.

New Laparoscopy Tools Advance Care for Common Gynecological Ailments

Tue, 24 Nov 2009 05:20:00 +1800

ORLANDO, Fla. - (Business Wire) Laparoscopic surgeons received their first glimpse of Cook Medicalâs uterine manipulator/injectors (UMI) last week at the 38th Global Congress of Minimally Invasive Gynecology, sponsored by the American Association of Gynecologic Laparoscopists (AAGL).

The OR Goes Hollywood

Tue, 24 Nov 2009 05:20:00 +1800

A visionary surgeon looks to emerging technology outside of medicine to advance camera and video capabilities in the OR.

The first time a camera was hooked up to a laparoscope, it was a film camera. The archival films dating back to the 1940s and 1950s show enormous cameras hooked up in the OR to create the first film images of surgery. By the 1970s, a large video camera was suspended from the ceiling by a rope to hold its weight in the OR

Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA(R)

Mon, 23 Nov 2009 13:30:00 +1800

First in the Class of Sustained Follicle Stimulants Would Reduce the Number of Treatment Injections for Patients
WHITEHOUSE STATION, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ELONVAÂ® (corifollitropin alfa injection) as a treatment in controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program. If approved by the European Commission, Merck would receive marketing authorization for ELONVA with unified labeling valid in all European Union Member States.

Practice offers advanced gynecological, obstetrics care

Mon, 23 Nov 2009 13:30:00 +1800

GREATER AKRON - Established by one doctor in 1990 as a womenâs health care practice in Hudson, The Reserve now offers cutting-edge gynecological and obstetrics care by nine certified physicians in three Summit County locations.
'We really have taken things to the next level,' said Dr. Ross Marchetta, the practiceâs founder.